Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adjuvanted quadrivalent flu vacc (SA, inact) inj 0.5ml pfs
1404000H0AAANAN
|
Influenza | Influenza | Immunological Products and Vaccines | 3,090,942 |
|
Influenza vaccine (surface antigen, inact) inj 0.5ml pfs
1404000H0AAAFAF
|
Influenza | Influenza | Immunological Products and Vaccines | 1,371,586 |
|
Adjuvanted trivalent flu vacc (SA, inact) inj 0.5ml pfs
1404000H0AAAMAM
|
Influenza | Influenza | Immunological Products and Vaccines | 613,950 |
|
Trivalent Flu/Vac/SA inj 0.5ml pfs
1404000H0AAARAR
|
Influenza | Influenza | Immunological Products and Vaccines | 1,258 |
|
Influenza vaccine (split virion, inactivated) inj 0.5ml pfs
1404000H0AAAKAK
|
Influenza | Influenza | Immunological Products and Vaccines | 53 |
|
Flu/Vac/Split 15microg strain inj 0.1ml pfs
1404000H0AAAIAI
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Flu/Vac/Split 9microg strain inj 0.1ml pfs
1404000H0AAAHAH
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Influenza vacc (split virion, inactivated) inj 0.25ml pfs
1404000H0AAAGAG
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Influenza vaccine (split viron, inactivated) inj 0.7ml pfs
1404000H0AAAQAQ
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Quadrivalent influenza vacc (live attenuated) nsl susp 0.2ml
1404000H0AAAJAJ
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Quadrivalent influenza vaccine (rcmb) inj 0.5ml pfs
1404000H0AAAPAP
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Trivalent Flu/Vac/Split High Dose inj 0.5ml pfs
1404000H0AAALAL
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Trivalent influenza vacc (live attenuated) nsl susp 0.2ml ud
1404000H0AAASAS
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Trivalent Influenza vacc (split viron, inact) inj 0.5ml pfs
1404000H0AAAUAU
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Trivalent influenza vaccine (recombinant) inj 0.5ml pfs
1404000H0AAATAT
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.